HOME > COMMENTARY
COMMENTARY
-
Barkers on Drugs (7)
July 29, 2002
-
BARKER ON DRUGS (6) Great Results, Shame about the Forecasts
June 24, 2002
-
BARKER ON DRUGS(5)
June 3, 2002
-
BARKER ON DRUGS(4)
April 22, 2002
-
Drastically Changing Marketing Strategy - The Best Strategy for Company Differentiation -
April 22, 2002
-
BARKER ON DRUGS (3)
March 11, 2002
-
BARKER ON DRUGS
February 18, 2002
-
Comarketing as a Marketing Strategy Option -1-
January 21, 2002
-
Comarketing as a Marketing Strategy Option -2-
January 21, 2002
-
Barker on Drugs (1)
January 14, 2002
-
Why Foreign-affiliated Companies Cannot Expand Their Market Share in Japan
July 9, 2001
-
< Special Contribution >What Are the Requirements for a Japanese Blockbuster Product? -2-
May 21, 2001
-
< Special Contribution >What Are the Requirements for a Japanese Blockbuster Product? -1-
May 21, 2001
-
Forecasting JapaneseDrug Industry Growth in FY2001
March 26, 2001
-
-1-
February 26, 2001
-
-2-
February 26, 2001
-
-1-
February 5, 2001
-
-2-
February 5, 2001
-
Advanced Technology and Segmentation of Companies
January 15, 2001
-
Don't Write Us Oldies Off!
January 15, 2001
ページ
The advance of cell therapy is one of the most exciting innovations in medical treatment in recent years. These drugs offer potential curative treatments for severe or previously fatal diseases. In this article, I will explain features and challenges in…
The Liberal Democratic Party (LDP) will wrap up its discussions on the FY2023 tax reform plan within a few days. Some provisions of the R&D tax credit system, which allow drug makers to deduct a portion of R&D expenses from…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…